Literature DB >> 26477301

Mini-review: Retarding aging in murine genetic models of neurodegeneration.

Roger L Albin1, Richard A Miller2.   

Abstract

Retardation of aging processes is a plausible approach to delaying the onset or slowing the progression of common neurodegenerative disorders. We review the results of experiments using murine genetic models of Alzheimer disease and Huntington disease to evaluate the effects of retarding aging. While positive results are reported in several of these experiments, there are several discrepancies in behavioral and pathologic outcomes both within and between different experiments. Similarly, different experiments yield varying assessments of potential proximate mechanisms of action of retarding aging. The anti-aging interventions used for some experiments include some that show only modest effects on lifespan, and others that have proven hard to reproduce. Several experiments used aggressive transgenic neurodegenerative disease models that may be less relevant in the context of age-related diseases. The experience with these models and interventions may be useful in designing future experiments assessing anti-aging interventions for disease-modifying treatment of neurodegenerative diseases. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Alzheimer disease; Amyloid; Huntington disease; Neurodegeneration; Polyglutamine; Senescence

Mesh:

Year:  2015        PMID: 26477301      PMCID: PMC4688232          DOI: 10.1016/j.nbd.2015.10.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  49 in total

Review 1.  Promoting health and longevity through diet: from model organisms to humans.

Authors:  Luigi Fontana; Linda Partridge
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

2.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

3.  Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.

Authors:  Edward C Stack; James K Kubilus; Karen Smith; Kerry Cormier; Steven J Del Signore; Emmanuel Guelin; Hoon Ryu; Steven M Hersch; Robert J Ferrante
Journal:  J Comp Neurol       Date:  2005-10-03       Impact factor: 3.215

4.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Authors:  L Holcomb; M N Gordon; E McGowan; X Yu; S Benkovic; P Jantzen; K Wright; I Saad; R Mueller; D Morgan; S Sanders; C Zehr; K O'Campo; J Hardy; C M Prada; C Eckman; S Younkin; K Hsiao; K Duff
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

5.  Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models.

Authors:  Nilay V Patel; Marcia N Gordon; Karen E Connor; Robert A Good; Robert W Engelman; Jerimiah Mason; David G Morgan; Todd E Morgan; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2004-11-25       Impact factor: 4.673

6.  Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Authors:  Ehud Cohen; Johan F Paulsson; Pablo Blinder; Tal Burstyn-Cohen; Deguo Du; Gabriela Estepa; Anthony Adame; Hang M Pham; Martin Holzenberger; Jeffery W Kelly; Eliezer Masliah; Andrew Dillin
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

7.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control.

Authors:  Massimiliano Bonafè; Michelangela Barbieri; Francesca Marchegiani; Fabiola Olivieri; Emilia Ragno; Claudia Giampieri; Elena Mugianesi; Matteo Centurelli; Claudio Franceschi; Giuseppe Paolisso
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

9.  Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia.

Authors:  Gemma Llovera; Kerstin Hofmann; Stefan Roth; Angelica Salas-Pérdomo; Maura Ferrer-Ferrer; Carlo Perego; Elisa R Zanier; Uta Mamrak; Andre Rex; Hélène Party; Véronique Agin; Claudine Fauchon; Cyrille Orset; Benoît Haelewyn; Maria-Grazia De Simoni; Ulrich Dirnagl; Ulrike Grittner; Anna M Planas; Nikolaus Plesnila; Denis Vivien; Arthur Liesz
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

10.  Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1.

Authors:  Colin Selman; Linda Partridge; Dominic J Withers
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

View more
  6 in total

Review 1.  Polyglutamine Repeats in Neurodegenerative Diseases.

Authors:  Andrew P Lieberman; Vikram G Shakkottai; Roger L Albin
Journal:  Annu Rev Pathol       Date:  2018-08-08       Impact factor: 23.472

Review 2.  Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.

Authors:  Meric A Altinoz; Aysel Ozpinar; Alp Ozpinar; Emily Hacker
Journal:  Metab Brain Dis       Date:  2019-10-17       Impact factor: 3.584

Review 3.  Shining light on the head: Photobiomodulation for brain disorders.

Authors:  Michael R Hamblin
Journal:  BBA Clin       Date:  2016-10-01

4.  Modeling Alzheimer's disease in progeria mice. An age-related concept.

Authors:  Kavita Sharma; Martin Darvas; C Dirk Keene; Laura J Niedernhofer; Warren Ladiges
Journal:  Pathobiol Aging Age Relat Dis       Date:  2018-10-04

5.  Behavioural Characterisation of Macrod1 and Macrod2 Knockout Mice.

Authors:  Kerryanne Crawford; Peter L Oliver; Thomas Agnew; Benjamin H M Hunn; Ivan Ahel
Journal:  Cells       Date:  2021-02-10       Impact factor: 7.666

6.  Therapeutic Targeting of Histone Deacetylation to Prevent Alzheimer's Disease.

Authors:  Sophia Chacko; Warren Ladiges
Journal:  Emed Res       Date:  2021-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.